Advertisement

Topics

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

00:12 EDT 14 Sep 2017 | Medical Xpress

A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology. The results are being presented today by the University at Buffalo researcher who led the study at the annual meeting of the European Association for the Study of Diabetes in Lisbon.

Original Article: Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

NEXT ARTICLE

More From BioPortfolio on "Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients"

Quick Search
Advertisement
 

Relevant Topics

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...